Merck & Co., Inc. — Director's Dealing 2014

Nov 25, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-11-24

Reporting Person: Schechter Adam H (EVP & Pres-Global Human Health)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-24	Phantom Stock	$	S	2778.8800	Disposed		Common Stock (2778.8800)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70794.9747	Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each share of phantom stock is the economic equivalent of one share of Merck common stock and was granted under the Merck & Co., Inc. Deferral Program (the "Program"). The Program includes the right of redesignation to other investment measures within the Program.